BAL
iPath Series B Bloomberg Cotton Subindex Total Return ETN
Set alert
52-week range unavailable
- Open
- 59.85
- Prev close
- 61.00
- Mkt cap
- 4.79M
- Vol
- 1.03K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 59.85
- High
- 61.00
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 60.90
- 200-d avg
- 59.46
News
5 days ago gurufocus.com
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
[url="]Agenus Inc. (Nasdaq: AGEN)[/url], a leader in immuno-oncology innovation, today announced early Phase 2 results from the mismatch repair-deficient (dMMR)
3 weeks ago gurufocus.com
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of
4 weeks ago gurufocus.com
Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
[url="]Agenus Inc.[/url] (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that two posters highlighting research on botensilimab (BOT), a
2 months ago gurufocus.com
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of mature Phase 1b results from t
2 months ago gurufocus.com
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the inves
4 months ago gurufocus.com
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study
6 months ago globenewswire.com
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support antibiotic BAL2420 (LptA inhibitor)…
7 months ago globenewswire.com
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial…
1 year ago globenewswire.com
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, September 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to…
1 year ago globenewswire.com
MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
Addition of AgenT-797 with Checkpoint Inhibitors, BOT/BAL, and Chemotherapy Demonstrates Robust Immune Activation, Offering Potential to Overcome Refractory Gastric Cancers Addition of AgenT-797 with…
1 year ago globenewswire.com
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant…
3 years ago headlinesoftoday.com
Best Agro to Increase its Market Share by 20%, will also Invest to Enhance Manufacturing Capabilities
Best Agrolife Ltd. (BAL) (BSE: BESTAGRO 539660), India’s leading agrochemicals manufacturer, has announced its medium to long-term target to gain 15-20% market share. The company is also enhancing…
3 years ago zacks.com
Can El Nino Boost Agricultural ETFs?
El Niño, a warm-water phenomenon that blows up off the Pacific coast of South America, often has a great impact on agricultural prices. El Nino causes weather disruptions in many regions around the…
4 years ago headlinesoftoday.com
Best Agrolife Ltd. Receives A- Credit Rating From Care Ratings
Indian agrochemical major Best Agrolife Ltd. (BAL) on Friday informed that CARE Ratings Limited has assigned a ‘CARE A-’ rating to the long-term bank facilities of the company with a stable outlook.…
4 years ago zacks.com
ETFs That Won After Fed Rate Hike
The Federal Reserve hike benchmark interest rates by another 75 bps on Sep 21 and hinted about future hawkish stances.
4 years ago zacks.com
Best-Performing ETFs of August Up At Least 15%
These ETFs gained at least 15% in the downbeat month of August.
4 years ago headlinesoftoday.com
Best Agrolife Ltd. to be The First Agrochemical Company in India to Manufacture Pyroxasulfone Technical
Best Agrolife Limited, a leading player in the Indian agrochemical industry, has been granted registration for the indigenous manufacturing of Pyroxasulfone technical u/s 9(3) by Central Insecticides…
4 years ago etftrends.com
Cotton ETN Surges as Drought Decimates Crops
Cotton prices and a related exchange traded note have surged over the past month as drought conditions decimate crops, with the latest harvest expected to be the smallest in 13 years. The iPath…
4 years ago zacks.com
Best ETF Areas of Last Week
Wall Street was upbeat last week with the S&P 500, the Dow Jones, the Nasdaq and the Russell 2000 all adding solid gains.
4 years ago zacks.com
ETF Areas Defying the Bear Market This Year: Can They Rally?
The year 2022 as a whole could easily be attributed to the Russia-Ukraine war, red-hot inflation and rising-rate worries after an upbeat 2021.
-
13 years ago benzinga.com
ETFs to Watch January 18, 2013 (BAL, HAO, XLI)
ETFs to Watch January 18, 2013 (BAL, HAO, XLI)
-
13 years ago benzinga.com
ETFs to Watch December 10, 2012 (IYW, MCHI, TBT)
ETFs to Watch December 10, 2012 (IYW, MCHI, TBT)
-
14 years ago benzinga.com
ETFs to Watch March 6, 2012 (BZQ, YCS, SQQQ)
ETFs to Watch March 6, 2012 (BZQ, YCS, SQQQ)
-
14 years ago benzinga.com
ETFs to Watch February 17, 2012 (QID, EZA, FXB)
ETFs to Watch February 17, 2012 (QID, EZA, FXB)
-
15 years ago benzinga.com
ETFs To Watch July 1, 2011 (FXA, EPI, DIG, SMN)
ETFs To Watch July 1, 2011 (FXA, EPI, DIG, SMN)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers, May 10th (DRN, BAL, EDC, SGG)
Benzinga's Top ETF Gainers, May 10th (DRN, BAL, EDC, SGG)
-
15 years ago benzinga.com
Benzinga's Top ETF Decliners, April 27th (ZSL, BAL, DZZ, DAG)
Benzinga's Top ETF Decliners, April 27th (ZSL, BAL, DZZ, DAG)
-
15 years ago benzinga.com
ETFs To Watch April 19, 2011 (BAL, RSW, EDZ, EUO)
ETFs To Watch April 19, 2011 (BAL, RSW, EDZ, EUO)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers, February 28th (DRN, BAL, AGQ, SOXS)
Benzinga's Top ETF Gainers, February 28th (DRN, BAL, AGQ, SOXS)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers, February 25th (SOXL, TNA, DRN, BAL)
Benzinga's Top ETF Gainers, February 25th (SOXL, TNA, DRN, BAL)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers, February 7th (BAL, FAS, SCO, DRN)
Benzinga's Top ETF Gainers, February 7th (BAL, FAS, SCO, DRN)
-
15 years ago benzinga.com
Benzinga's Top ETF Decliners, February 4th (SOXS, UCO, BAL, SSG)
Benzinga's Top ETF Decliners, February 4th (SOXS, UCO, BAL, SSG)
-
15 years ago benzinga.com
ETFs To Watch January 20, 2011 (BAL, BZQ, FAZ, TLT)
ETFs To Watch January 20, 2011 (BAL, BZQ, FAZ, TLT)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers, January 18th (TAN, AGQ, BAL, DRN, PALL)
Benzinga's Top ETF Gainers, January 18th (TAN, AGQ, BAL, DRN, PALL)
-
15 years ago benzinga.com
Benzinga's Top ETF Gainers (BAL, UNG, DRN, ITB)
Benzinga's Top ETF Gainers (BAL, UNG, DRN, ITB)
-
15 years ago benzinga.com
ETFs To Watch November 15, 2010 (BAL, DRR, FXP, TFI)
ETFs To Watch November 15, 2010 (BAL, DRR, FXP, TFI)
-
16 years ago benzinga.com
ETFs To Watch September 29, 2010 (DIG, FXF, TUR, SOXL)
ETFs To Watch September 29, 2010 (DIG, FXF, TUR, SOXL)
-
16 years ago benzinga.com
ETFs To Watch February 18, 2010 (IYW, DZZ, BAL, TUR)
ETFs To Watch February 18, 2010 (IYW, DZZ, BAL, TUR)
-
16 years ago benzinga.com
ETFs To Watch February 10, 2010 (EWI, BAL, OIH, MXI)
ETFs To Watch February 10, 2010 (EWI, BAL, OIH, MXI)